Santen Pharmaceutical Co (JP:4536) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Santen Pharmaceutical Co., Ltd. has announced the buyback of 1,348,400 of its common shares for a total of 2.388 billion yen, which took place from September 1 to September 30, 2024. This buyback is part of a larger program approved by the Board of Directors, with a maximum of 21.11 million shares to be repurchased by November 6, 2024. To date, a cumulative total of 14,178,600 shares have been repurchased for 23.639 billion yen.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
